Casdin Capital’s Revolution Medicines RVMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $106M | Sell |
2,887,933
-810,000
| -22% | -$29.8M | 9.68% | 3 |
|
|
2025
Q1 | $131M | Sell |
3,697,933
-1,350
| -0% | -$47.7K | 10.68% | 3 |
|
|
2024
Q4 | $162M | Sell |
3,699,283
-415,000
| -10% | -$18.2M | 10.77% | 3 |
|
|
2024
Q3 | $187M | Sell |
4,114,283
-292,592
| -7% | -$13.3M | 12.44% | 2 |
|
|
2024
Q2 | $171M | Sell |
4,406,875
-1,210,724
| -22% | -$47M | 13.06% | 2 |
|
|
2024
Q1 | $181M | Sell |
5,617,599
-97,176
| -2% | -$3.13M | 13.46% | 1 |
|
|
2023
Q4 | $164M | Buy |
5,714,775
+3,904,775
| +216% | +$112M | 16.09% | 1 |
|
|
2023
Q3 | $50.1M | Hold |
1,810,000
| – | – | 5.55% | 6 |
|
|
2023
Q2 | $48.4M | Hold |
1,810,000
| – | – | 4.23% | 7 |
|
|
2023
Q1 | $39.2M | Sell |
1,810,000
-715,000
| -28% | -$15.5M | 3.23% | 9 |
|
|
2022
Q4 | $60.1M | Buy |
2,525,000
+2,700
| +0.1% | +$64.3K | 4.66% | 7 |
|
|
2022
Q3 | $49.7M | Buy |
2,522,300
+152,300
| +6% | +$3M | 3.27% | 10 |
|
|
2022
Q2 | $46.2M | Hold |
2,370,000
| – | – | 3.91% | 11 |
|
|
2022
Q1 | $60.5M | Hold |
2,370,000
| – | – | 2.71% | 16 |
|
|
2021
Q4 | $59.7M | Sell |
2,370,000
-430,000
| -15% | -$10.8M | 1.68% | 22 |
|
|
2021
Q3 | $77M | Buy |
2,800,000
+495,000
| +21% | +$13.6M | 1.92% | 20 |
|
|
2021
Q2 | $73.2M | Buy |
2,305,000
+460,465
| +25% | +$14.6M | 1.86% | 18 |
|
|
2021
Q1 | $84.6M | Buy |
1,844,535
+210,000
| +13% | +$9.63M | 2.52% | 14 |
|
|
2020
Q4 | $64.7M | Hold |
1,634,535
| – | – | 1.92% | 15 |
|
|
2020
Q3 | $56.9M | Buy |
1,634,535
+299,999
| +22% | +$10.4M | 2.55% | 11 |
|
|
2020
Q2 | $42.1M | Buy |
1,334,536
+15,000
| +1% | +$474K | 2.49% | 14 |
|
|
2020
Q1 | $28.9M | Buy |
+1,319,536
| New | +$28.9M | 3.07% | 12 |
|